Author |
Topic Search Topic Options
|
dono7392
Newbie
Joined: Nov 24 2019
Location: Wisconsin
Status: Offline
Points: 14
|
Post Options
Thanks(0)
Quote Reply
Topic: Is it TNBC if 20% of cells are Her2+? Posted: Dec 03 2019 at 6:39pm |
Doctors want to treat me with chemo designed for both TNBC and Her2+ because about 20% of my tumor is just above equivocal amplification for Her2.. I would imagine that they have to pick one type of cancer to treat before deciding treatment. Has anyone else experienced this?
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 05 2019 at 4:02am |
That really sounds amazing! What 0hase are.the trials?
|
|
strongtogether
Groupie
Joined: Aug 07 2019
Location: Australia
Status: Offline
Points: 88
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 05 2019 at 8:06pm |
I'm sorry fulltilt but I don't understand. Do you work for Cytodyn, or are you a patient of theirs or what? Does all tnbc have CCR5? Is it used for treating stage4 patients currently?
|
|
Kellyless
Senior Member
Joined: Jun 18 2009
Location: Dallas, Texas
Status: Offline
Points: 1154
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 05 2019 at 8:14pm |
For clarification, the 800 patients mentioned are HIV patients. It looks like they've had one or two stage 4 TNBC patients maybe? I can only find information published by Cytodyn themselves, and yes they are a for profit venture. FullTilt, please reach out to the site administrator and get clearance to promote your information here to our TNBC cancer survivor community. Thank you.
|
IDC, 2.2 cm, Stage IIb,lumpectomy 1/30/09 ACx4,Tx4 36 rads 6/1/16 Local recurrence same breast, same spot 1.8cm Carb.4x every 3 wks, Taxol 12x once wk. Dbl Mast. PCR!! Reconstruction fail, NED!
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 05 2019 at 8:27pm |
Fulltilt,
Your study only looked at 2 TNBC metastatic patients and looked at circulating tumor cells? I think a study that is a huge breakthrough needs to be much larger than 2 people. What are the end points of the study? Did it only look at circulating cells? Did the tumors completely become no evidence of disease? What happened when they stopped the study drug? Did the tumors start growing again?
This thread was talking about someone who's tumor was TNBC but also had a portion that was Her2+. Your study would not benefit this person so I'm not sure this is the appropriate place to post. You should get permission from the admins about posting in the Metastatic forum.
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|
123Donna
Senior Member
Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13509
|
Post Options
Thanks(0)
Quote Reply
Posted: Dec 08 2019 at 11:12am |
|
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09) 11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15
|
|